You are here

Aerie Pharmaceuticals

No big bang for biopharma buyouts

EP Vantage

Wed, 10/5/22 - 10:29 am

Global Blood Therapeutics

Aerie Pharmaceuticals

Gilead Sciences

Aerie’s glaucoma drug journey ends in $770M sale to Alcon

BioPharma Dive

Tue, 08/23/22 - 10:40 am

Aerie Pharmaceuticals

Aerie touts silver linings from failed PhIIb, plots PhIII in dry eye disease

Endpoints

Thu, 09/16/21 - 10:58 am

Aerie Pharmaceuticals

clinical trials

dry eye disease

Aerie Pharmaceuticals hires former Allergan, Alcon exec to help lead clinical, medical affairs

Fierce Biotech

Mon, 02/3/20 - 10:35 am

Aerie Pharmaceuticals

medical affairs

Aerie Pharmaceuticals agrees to acquire Avizorex Pharma

Pharmaceutical Business Review

Tue, 11/19/19 - 09:59 am

Aerie Pharmaceuticals

Avizorex Pharma

dry eye disease

Aerie (AERI) Starts Phase II Study on Eye Candidate in Japan

Yahoo/Zacks.com

Sat, 03/23/19 - 11:40 am

Aerie Pharmaceuticals

clinical trials

Open-Angle Glaucoma